325 related articles for article (PubMed ID: 12592062)
21. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men.
O'Connor KG; Tobin JD; Harman SM; Plato CC; Roy TA; Sherman SS; Blackman MR
J Gerontol A Biol Sci Med Sci; 1998 May; 53(3):M176-82. PubMed ID: 9597048
[TBL] [Abstract][Full Text] [Related]
22. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Bellantoni MF; Harman SM; Cho DE; Blackman MR
J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
[TBL] [Abstract][Full Text] [Related]
23. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
24. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
Manns PJ; Williams DP; Snow CM; Wander RC
Am J Hum Biol; 2003; 15(1):91-100. PubMed ID: 12552583
[TBL] [Abstract][Full Text] [Related]
25. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
26. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal associations of the endocrine environment on fat partitioning in postmenopausal women.
Goss AM; Darnell BE; Brown MA; Oster RA; Gower BA
Obesity (Silver Spring); 2012 May; 20(5):939-44. PubMed ID: 22173571
[TBL] [Abstract][Full Text] [Related]
28. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
[TBL] [Abstract][Full Text] [Related]
29. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity.
Söderberg S; Olsson T; Eliasson M; Johnson O; Brismar K; Carlström K; Ahrén B
Int J Obes Relat Metab Disord; 2001 Jan; 25(1):98-105. PubMed ID: 11244464
[TBL] [Abstract][Full Text] [Related]
30. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
31. Effects of aging and estradiol supplementation on GH axis dynamics in women.
Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
33. The effect of growth hormone on bioactive IGF in overweight/obese women.
Dichtel LE; Bjerre M; Schorr M; Bredella MA; Gerweck AV; Russell BM; Frystyk J; Miller KK
Growth Horm IGF Res; 2018 Jun; 40():20-27. PubMed ID: 29679919
[TBL] [Abstract][Full Text] [Related]
34. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
[TBL] [Abstract][Full Text] [Related]
35. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
Thomas T; Burguera B; Melton LJ; Atkinson EJ; O'Fallon WM; Riggs BL; Khosla S
Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
[TBL] [Abstract][Full Text] [Related]
36. Metabolic effects of oestrogens: impact of the route of administration.
Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.
Gibney J; Johannsson G; Leung KC; Ho KK
J Clin Endocrinol Metab; 2005 Jul; 90(7):3897-903. PubMed ID: 15855258
[TBL] [Abstract][Full Text] [Related]
38. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding.
Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S
Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484
[TBL] [Abstract][Full Text] [Related]
39. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
[TBL] [Abstract][Full Text] [Related]
40. Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels.
Bondanelli M; Margutti A; Ambrosio MR; Plaino L; Cobellis L; Petraglia F; degli Uberti EC
J Clin Endocrinol Metab; 2001 May; 86(5):1973-80. PubMed ID: 11344194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
